Add
SUPN to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| SUPN > SEC Filings for SUPN > Form 8-K on 8-Nov-2012 | All Recent SEC Filings |
8-Nov-2012
Results of Operations and Financial Condition, Other Events, Financi
On November 7, 2012, Supernus Pharmaceuticals, Inc. (the "Company") issued a press release describing the Company's financial results for the three and nine month periods ending September 30, 2012. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
On November 5, 2012, Supernus Pharmaceuticals, Inc. (the "Company") issued a press release announcing the issuance of two patents by the US Patent and Trademark Office covering Trokendi XR™. A copy of this press release is furnished as Exhibit 99.2 hereto and is incorporated herein by reference.
(d) The following documents are furnished as Exhibits pursuant to Item 2.02 and Item 8.01, respectively, hereof:
Exhibit 99.1 - The following document is furnished November 7, 2012 of the Company regarding financial performance for the three and nine month periods ending September 30, 2012.
Exhibit 99.2 - Press Release dated November 5, 2012 of the Company regarding receipt of approval of two patents from the USPTO.
|
|